These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7351034)
1. Pulmonary leukostasis and its relationship to pulmonary dysfunction in sheep and rabbits. Fountain SW; Martin BA; Musclow CE; Cooper JD Circ Res; 1980 Feb; 46(2):175-80. PubMed ID: 7351034 [TBL] [Abstract][Full Text] [Related]
2. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. Craddock PR; Fehr J; Brigham KL; Kronenberg RS; Jacob HS N Engl J Med; 1977 Apr; 296(14):769-74. PubMed ID: 840277 [TBL] [Abstract][Full Text] [Related]
4. Pneumococcal sonicate-induced biphasic granulocytopenia and its dissociation from pulmonary leukostasis. The contribution of pneumococcal products and complement to early and late granulocytopenic phases. Goldblum SE; Reed WP; Thilsted JP J Lab Clin Med; 1983 Dec; 102(6):987-99. PubMed ID: 6644159 [TBL] [Abstract][Full Text] [Related]
5. Thromboxane synthesis by sources other than platelets in association with complement-induced pulmonary leukostasis and pulmonary hypertension in sheep. McDonald JW; Ali M; Morgan E; Townsend ER; Cooper JD Circ Res; 1983 Jan; 52(1):1-6. PubMed ID: 6687354 [TBL] [Abstract][Full Text] [Related]
6. Role of intrapulmonary release of eicosanoids and superoxide anion as mediators of pulmonary dysfunction and endothelial injury in sheep with intermittent complement activation. Perkowski SZ; Havill AM; Flynn JT; Gee MH Circ Res; 1983 Nov; 53(5):574-83. PubMed ID: 6313251 [TBL] [Abstract][Full Text] [Related]
7. Contribution of circulating formed elements to prostanoid production in complement-mediated lung injury in sheep. Egan TM; Saunders NR; Dubois P; Choiniere L; McDonald JW; Cooper JD Surgery; 1985 Aug; 98(2):350-8. PubMed ID: 4023926 [TBL] [Abstract][Full Text] [Related]
8. The effect of a single infusion of zymosan-activated plasma on the pulmonary microcirculation of sheep. Structure-function relationships. Meyrick BO; Brigham KL Am J Pathol; 1984 Jan; 114(1):32-45. PubMed ID: 6691415 [TBL] [Abstract][Full Text] [Related]
9. Species variability in the cardiovascular and hematologic effects of zymosan-activated plasma infusion. Casey LC; Fletcher JR; Chernow B; Ramwell PW J Surg Res; 1986 Mar; 40(3):202-9. PubMed ID: 3951216 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary hemodynamic effects of antisheep serum-induced leukopenia. Heath CA; Lai L; Bizios R; Malik AB J Leukoc Biol; 1986 Apr; 39(4):385-97. PubMed ID: 3456403 [TBL] [Abstract][Full Text] [Related]
11. Cardiopulmonary effects of cuprophane-activated plasma in the swine. Cheung AK; LeWinter M; Chenoweth DE; Lew WY; Henderson LW Kidney Int; 1986 Apr; 29(4):799-806. PubMed ID: 3086612 [TBL] [Abstract][Full Text] [Related]
12. The effect of an infusion of zymosan-activated plasma on hemodynamic and pulmonary function in sheep. Sharkey P; Judges D; Driedger AA; Cheung H; Finley RJ; Sibbald WJ Circ Shock; 1984; 12(2):79-93. PubMed ID: 6705153 [TBL] [Abstract][Full Text] [Related]
13. Production of acute pulmonary injury by leukocytes and activated complement. Hohn DC; Meyers AJ; Gherini ST; Beckmann A; Markison RE; Churg AM Surgery; 1980 Jul; 88(1):48-58. PubMed ID: 7385023 [TBL] [Abstract][Full Text] [Related]
14. Preservation of platelets during extracorporeal circulation in sheep. A comparison between aspirin and sulfinpyrazone. Townsend ER; Duffin J; Ali M; McDonald JW; Thiesson JJ; Masterson J; Klement P; Cooper JD Circ Res; 1981 Aug; 49(2):452-7. PubMed ID: 7249281 [TBL] [Abstract][Full Text] [Related]
15. Activation of complement at plasma-air or serum-air interface of rabbits. Ward CA; Koheil A; McCullough D; Johnson WR; Fraser WD J Appl Physiol (1985); 1986 May; 60(5):1651-8. PubMed ID: 3710983 [TBL] [Abstract][Full Text] [Related]
16. Prostaglandin production associated with the pulmonary vascular response to complement activation. Cooper JD; McDonald JW; Ali M; Menkes E; Masterson J; Klement P Surgery; 1980 Aug; 88(2):215-21. PubMed ID: 7394704 [No Abstract] [Full Text] [Related]
17. Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep. Smallbone BW; Taylor NE; McDonald JW J Pharmacol Exp Ther; 1987 Sep; 242(3):1035-40. PubMed ID: 2821222 [TBL] [Abstract][Full Text] [Related]
18. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. Craddock PR; Hammerschmidt D; White JG; Dalmosso AP; Jacob HS J Clin Invest; 1977 Jul; 60(1):260-4. PubMed ID: 874088 [TBL] [Abstract][Full Text] [Related]
19. Additive effect of intravascular complement activation and brief episodes of hypoxia in producing increased permeability in the rabbit lung. Larsen GL; Webster RO; Worthen GS; Gumbay RS; Henson PM J Clin Invest; 1985 Mar; 75(3):902-10. PubMed ID: 3980730 [TBL] [Abstract][Full Text] [Related]
20. Effects of verapamil on thromboxane synthesis and pulmonary hypertension in sheep. Smallbone BW; Davies BJ; Noulty EJ; Pisters LL; Taylor NE; McDonald JW Clin Invest Med; 1986; 9(3):145-9. PubMed ID: 3757320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]